Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  CSPC Pharmaceutical Group Limited    1093   HK1093012172

CSPC PHARMACEUTICAL GROUP LIMITED

(1093)
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
10/14/2019 10/15/2019 10/16/2019 10/17/2019 10/18/2019 Date
16.7 16.74 16.8 16.9 17.4 Last
61602319 25828494 19713908 21189170 33956018 Volume
+4.24% +0.24% +0.36% +0.60% +2.96% Change
Financials (HKD)
Sales 2019 25 319 M
EBIT 2019 5 364 M
Net income 2019 4 382 M
Finance 2019 6 627 M
Yield 2019 1,39%
Sales 2020 30 573 M
EBIT 2020 6 745 M
Net income 2020 5 345 M
Finance 2020 8 345 M
Yield 2020 1,64%
P/E ratio 2019 24,8x
P/E ratio 2020 20,4x
EV / Sales2019 4,02x
EV / Sales2020 3,28x
Capitalization 109 B
More Financials
Company
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs),... 
Sector
Pharmaceuticals
Calendar
11/19Earnings Release
More about the company
Surperformance© ratings of CSPC Pharmaceutical Group
Trading Rating : Investor Rating :
More Ratings
Latest news on CSPC PHARMACEUTICAL GROUP
10/18CSPC PHARMACEUTICAL : Voluntary announcement - first-in-class product candidate ..
PU
10/14CSPC PHARMACEUTICAL : Inside information - announcement on the indicative result..
PU
10/08China, Hong Kong stocks rise on stimulus hopes; trade talks in focus
RE
09/26CSPC PHARMACEUTICAL : Voluntary announcement - drug registration approval of the..
PU
09/26CSPC PHARMACEUTICAL : Voluntary announcement - drug registration approval of the..
PU
09/23CSPC PHARMACEUTICAL : First-in-class product candidate almb-0168 was granted orp..
PU
09/12NOTIFICATION LETTER AND REQUEST FORM : Notice of publication of 2019 interim rep..
PU
09/10ASIA MARKETS: Asian Markets Gain Ahead Of ECB Meeting
DJ
09/10CSPC PHARMACEUTICAL : Voluntary announcement - passing of consistency evaluation..
PU
09/02CSPC PHARMACEUTICAL : Voluntary announcement - recombinant anti-her2 and anti-cd..
PU
08/21ASIA MARKETS: Asian Markets Pull Back After Recession Fears Weigh On Wall Str..
DJ
05/30ASIA MARKETS: Asian Markets In A Tug Of War As Investors Eye Trade Spat
DJ
05/30CSPC PHARMACEUTICAL GROUP LTD : Ex-dividend day for final dividend
FA
05/27CSPC PHARMACEUTICAL GROUP LTD : Press Release
CO
05/10ASIA MARKETS: China Stocks Soar To Best One-day Gain Since March, As U.S. Tar..
DJ
More news
News in other languages on CSPC PHARMACEUTICAL GROUP
05/30CSPC PHARMACEUTICAL GROUP LTD : Ex-dividend day for final dividend
2018CSPC PHARMACEUTICAL GROUP LTD : publication des résultats trimestriels
2018CSPC PHARMACEUTICAL GROUP LTD : Veröffentlichung des Quartalsergebnisses
2018CSPC PHARMACEUTICAL GROUP LTD : Ex-dividend day for final dividend
2018CSPC PHARMACEUTICAL GROUP LTD : publication des résultats trimestriels
More news
Analyst Recommendations on CSPC PHARMACEUTICAL GROUP
More recommendations
Sector news : Pharmaceuticals - NEC
10/19JOHNSON & JOHNSON : J&J Recalls Baby Powder on Asbestos Concern -- 3rd Update
DJ
10/19J&J Recalls Baby Powder For Asbestos -- WSJ
DJ
10/18More Money Demanded in Opioid Settlement Talks -- Update
DJ
10/18More Money Demanded in Opioid Settlement Talks
DJ
10/18JOHNSON & JOHNSON : J&J Recalls Baby Powder on Asbestos Concern -- 2nd Update
DJ
More sector news : Pharmaceuticals - NEC
Chart CSPC PHARMACEUTICAL GROUP LIMITED
Duration : Period :
CSPC Pharmaceutical Group Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CSPC PHARMACEUTICAL GROUP
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 29
Average target price 18,72  HKD
Last Close Price 17,40  HKD
Spread / Highest target 55,6%
Spread / Average Target 7,56%
Spread / Lowest Target -19,5%
EPS Revisions
Managers
NameTitle
Dong Chen Cai Chairman & Co-Chief Executive Officer
Cuilong Zhang Vice Chairman & Co-Chief Executive Officer
Wei Dong Pan Executive Director
Ka Sze Lee Secretary & Non-Executive Director
Huai Yu Wang Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CSPC PHARMACEUTICAL GROUP LIMITED54.53%13 837
JOHNSON & JOHNSON5.52%337 021
ROCHE HOLDING AG18.49%250 869
MERCK AND COMPANY10.82%216 813
PFIZER-16.47%201 662
NOVARTIS15.95%198 751